S. 637 · 116th Congress
Combatting Unreasonable Rises and Excessively High Drug Prices Act
- Stage
- In committee
- Sponsor
- Richard Blumenthal
- Introduced
- 2019-02-28
- Latest action
- 2019-02-28 · Introduced in Senate
Summary
Combatting Unreasonable Rises and Excessively High Drug Prices Act or the CURE High Drug Prices Act
This bill prohibits price gouging by manufacturers of prescription drugs (including a combination of a drug, device, or biological product) that are covered by a federal health care program. The bill specifies percentage increases in price at which price gouging is presumed.